BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10492360)

  • 1. Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.
    Higashi T; Sakahara H; Torizuka T; Nakamoto Y; Kanamori S; Hiraoka M; Imamura M; Nishimura Y; Tamaki N; Konishi J
    J Nucl Med; 1999 Sep; 40(9):1424-33. PubMed ID: 10492360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer.
    Yoshioka M; Sato T; Furuya T; Shibata S; Andoh H; Asanuma Y; Hatazawa J; Shimosegawa E; Koyama K; Yamamoto Y
    J Gastroenterol; 2004 Jan; 39(1):50-5. PubMed ID: 14767734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor response and patterns of failure following intraoperative radiotherapy for unresectable pancreatic cancer--evaluation by computed tomography.
    Kanamori S; Nishimura Y; Kokubo M; Sasai K; Hiraoka M; Shibamoto Y; Hosotani R; Imamura M; Abe M
    Acta Oncol; 1999; 38(2):215-20. PubMed ID: 10227444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI; Kim SK; Paeng JC; Lee HY
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer.
    Nakata B; Nishimura S; Ishikawa T; Ohira M; Nishino H; Kawabe J; Ochi H; Hirakawa K
    Int J Oncol; 2001 Jul; 19(1):53-8. PubMed ID: 11408922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.
    Toesca DAS; Pollom EL; Poullos PD; Flynt L; Cui Y; Quon A; von Eyben R; Koong AC; Chang DT
    Pract Radiat Oncol; 2017; 7(2):120-125. PubMed ID: 28274396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.
    Cascini GL; Avallone A; Delrio P; Guida C; Tatangelo F; Marone P; Aloj L; De Martinis F; Comella P; Parisi V; Lastoria S
    J Nucl Med; 2006 Aug; 47(8):1241-8. PubMed ID: 16883000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.
    Nakata B; Chung YS; Nishimura S; Nishihara T; Sakurai Y; Sawada T; Okamura T; Kawabe J; Ochi H; Sowa M
    Cancer; 1997 Feb; 79(4):695-9. PubMed ID: 9024707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
    Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer.
    Wakabayashi H; Nishiyama Y; Otani T; Sano T; Yachida S; Okano K; Izuishi K; Suzuki Y
    World J Gastroenterol; 2008 Jan; 14(1):64-9. PubMed ID: 18176963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of pancreatic carcinoma: role of FDG PET.
    Keogan MT; Tyler D; Clark L; Branch MS; McDermott VG; DeLong DM; Coleman RE
    AJR Am J Roentgenol; 1998 Dec; 171(6):1565-70. PubMed ID: 9843289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of liver metastases from pancreatic cancer using FDG PET.
    Fröhlich A; Diederichs CG; Staib L; Vogel J; Beger HG; Reske SN
    J Nucl Med; 1999 Feb; 40(2):250-5. PubMed ID: 10025831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of unresectable pancreatic cancer to intraoperative radiotherapy.
    Mariya Y; Aoki M; Anbai A; Matsukura H; Abe Y; Kimura T; Matsuda K; Ohnuma H; Yokoyama S
    Radiat Med; 1998; 16(3):195-200. PubMed ID: 9715998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.